Notice bibliographique
Résumé
Molecular Assay for COVIDFigure: molecular assay, COVID, LumiraDx, SARS-CoV-2, Flu A/B RNA STAR, FDA, qSTAR technology, nucleic acid extraction, influenza A, influenza B, tourniquet, abdominal aortic, Junctional Tourniquet-Stabilized device, hemorrhages, pelvic bleeding, EMS, blood test, concussion, TBI blood test, i-STAT TBI Plasma test, brain injury, CT scan, biomarkersLumiraDx is planning to make its SARS-CoV-2 & Flu A/B RNA STAR Complete assay commercially available in the United States and United Kingdom. The assay received an Emergency Use Authorization from the U.S. Food and Drug Administration and validation for use by the UK Health Security Agency under the Coronavirus Test Device Approvals, according to a company news release. (Feb. 26, 2023; https://bit.ly/3lwMc3n.) The assay uses the qSTAR technology portfolio, which utilizes a single-step direct method for nucleic acid extraction and amplification on validated open RT-PCR instruments. This amplification technology identifies and differentiates those suspected of having a respiratory viral infection consistent with COVID. The assay can detect and differentiate between influenza A, influenza B, and SARS-CoV-2 infections within 20 minutes from a single sample. The assay has been available in the Europe Union since June 2022. Clearance for Tourniquet The U.S. Food and Drug Administration granted 510(k) clearance to Compression Works' Abdominal Aortic and Junctional Tourniquet-Stabilized (AAJT-S) device. The junctional tourniquet controls noncompressible hemorrhages and has multiuse capabilities including use in the axilla and groin to stop junctional hemorrhage, the abdomen for pelvic bleeding and bilateral lower leg injuries, and pelvic fracture stabilization. This device can be used by EMS to stabilize victims with broken pelvises and suspected bleeding until they can be transported to a surgical team. Compression Works recently presented the AAJT-S at the Western Trauma Association meeting in Alberta, Canada, for use in trauma environments where zone 3 resuscitative endothelial balloon occlusion of the aorta (REBOA) is currently used. The device has been used by the U.S. military and EMS since 2013, and clinical studies have shown its usefulness as an adjunct to REBOA, according to a news release from the company. (March 30, 2023; https://bit.ly/3oM2I1n.) Blood Test for Concussion Abbott received FDA clearance for a laboratory traumatic brain injury blood test. This is the first commercially available TBI blood test, according to a news release from the company. (March 7, 2023; https://bit.ly/3oNIZy0.) The approval comes after FDA clearance of the company's i-STAT TBI Plasma test, a rapid blood test for concussion used on their Alinity I laboratory instruments. A TBI blood test can now be run on the laboratory instrument for evaluating patients 18 and older presenting with suspected mild traumatic brain injury (Glasgow Coma Scale score 13-15) within 12 hours of injury to assist in determining the need for a CT scan. The results of a blood sample are available in 18 minutes. The blood test measures the complementary biomarkers ubiquitin C-terminal hydrolase L1 and glial fibrillary acidic protein in blood plasma and serum. MS. TALBOT is an editorial assistant for Emergency Medicine News. Share this article on Twitter and Facebook. Access the links in EMN by reading this on our website: www.EM-News.com. Comments? Write to us at [email protected].
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction distillée sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.
Scores Codex et Gemma par catégorie
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,001 | 0,001 |
| Méta-épidémiologie (sens strict) | 0,000 | 0,000 |
| Méta-épidémiologie (sens large) | 0,000 | 0,000 |
| Bibliométrie | 0,001 | 0,002 |
| Études des sciences et des technologies | 0,000 | 0,000 |
| Communication savante | 0,000 | 0,000 |
| Science ouverte | 0,000 | 0,000 |
| Intégrité de la recherche | 0,000 | 0,000 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,031 | 0,019 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; les deux têtes enseignantes s’accordent sur ce qui est montré ici.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».